UCSC Human Gene Sorter
 
genome assembly search
sort by display output 
#
Name
VisiGene
BLASTP
E-Value
Genome Position
Description
1SIT1n/a
n/a
n/a
n/a
5e-111chr9 35,650,113signaling threshold regulating transmembrane adaptor 1 (from RefSeq NM_014450.3)
2SLAMF6n/a
n/a
n/a
n/a
n/achr1 160,504,145SLAM family member 6, transcript variant 1 (from RefSeq NM_001184714.2)
3IKZF3n/a
n/a
n/a
n/a
n/achr17 39,811,015IKAROS family zinc finger 3, transcript variant 1 (from RefSeq NM_012481.5)
4IL2RBn/a
n/a
n/a
n/a
n/achr22 37,137,879interleukin 2 receptor subunit beta, transcript variant 1 (from RefSeq NM_000878.5)
5SCIMPn/a
n/a
n/a
n/a
n/achr17 5,221,890SLP adaptor and CSK interacting membrane protein, transcript variant 1 (from RefSeq NM_207103.3)
6P2RY10n/a
n/a
n/a
n/a
n/achrX 78,954,559P2Y receptor family member 10, transcript variant 1 (from RefSeq NM_014499.4)
7TLR10n/a
n/a
n/a
n/a
n/achr4 38,777,614toll like receptor 10, transcript variant 1 (from RefSeq NM_030956.4)
8SPNn/a
n/a
n/a
n/a
n/achr16 29,667,061sialophorin, transcript variant 2 (from RefSeq NM_003123.6)
9BLKn/a
n/a
n/a
n/a
n/achr8 11,529,493BLK proto-oncogene, Src family tyrosine kinase, transcript variant 1 (from RefSeq NM_001715.3)
10IGHJ1n/a
    
    
     
n/achr14 105,865,432J region of the variable domain of immunoglobulin heavy  chains that participates in the antigen recognition (PubMed:24600447).  Immunoglobulins, also known as antibodies, are membrane-bound or  secreted glycoproteins produced by B lymphocytes. In the recognition  phase of humoral immunity, the membrane-bound immunoglobulins serve as  receptors which, upon binding of a specific antigen, trigger the clonal  expansion and differentiation of B lymphocytes into immunoglobulins-  secreting plasma cells. Secreted immunoglobulins mediate the effector  phase of humoral immunity, which results in the elimination of bound  antigens (PubMed:22158414, PubMed:20176268). The antigen binding site  is formed by the variable domain of one heavy chain, together with that  of its associated light chain. Thus, each immunoglobulin has two  antigen binding sites with remarkable affinity for a particular  antigen. The variable domains are assembled by a process called V-(D)-J  rearrangement and can then be subjected to somatic hypermutations  which, after exposure to antigen and selection, allow affinity  maturation for a particular antigen (PubMed:20176268, PubMed:17576170). (from UniProt A0A0C4DH62)
11TNFRSF17n/a
n/a
n/a
n/a
n/achr16 11,966,639TNF receptor superfamily member 17 (from RefSeq NM_001192.3)
12PARP15n/a
n/a
n/a
n/a
n/achr3 122,608,348poly(ADP-ribose) polymerase family member 15, transcript variant 1 (from RefSeq NM_001113523.3)
13STAP1n/a
n/a
n/a
n/a
n/achr4 67,583,032signal transducing adaptor family member 1, transcript variant 1 (from RefSeq NM_012108.4)
14TNFn/a
    
    
     
n/achr6 31,576,950tumor necrosis factor (from RefSeq NM_000594.4)
15MIR142n/a
n/a
n/a
n/a
n/achr17 58,331,275microRNA 142 (from RefSeq NR_029683.1)
16TBC1D27Pn/a
n/a
n/a
n/a
n/achr17 16,928,250TBC1 domain family member 27, pseudogene (from HGNC TBC1D27P)
17ENSG00000290698n/a
n/a
n/a
n/a
n/achr17 16,928,877TBC1 domain family member 27, pseudogene (from RefSeq NR_147084.1)
18SP140n/a
n/a
n/a
n/a
n/achr2 230,269,475SP140 nuclear body protein, transcript variant 1 (from RefSeq NM_007237.5)
19IL24n/a
n/a
n/a
n/a
n/achr1 206,900,791interleukin 24, transcript variant 1 (from RefSeq NM_006850.3)
20PAX5n/a
n/a
n/a
n/a
n/achr9 36,933,768paired box 5, transcript variant 12 (from RefSeq NR_103999.2)
21CD80n/a
n/a
n/a
n/a
n/achr3 119,541,953CD80 molecule (from RefSeq NM_005191.4)
22ENSG00000269954n/a
    
    
     
n/achr8 11,558,591ENSG00000269954 (from geneSymbol)
23CD180n/a
n/a
n/a
n/a
n/achr5 67,188,206CD180 molecule (from RefSeq NM_005582.3)
24AICDAn/a
n/a
n/a
n/a
n/achr12 8,607,514activation induced cytidine deaminase, transcript variant 1 (from RefSeq NM_020661.4)
25IL21Rn/a
n/a
n/a
n/a
n/achr16 27,427,108interleukin 21 receptor, transcript variant 2 (from RefSeq NM_181078.3)
26CD226n/a
n/a
n/a
n/a
n/achr18 69,900,573CD226 molecule, transcript variant 2 (from RefSeq NM_001303618.2)
27LCKn/a
n/a
n/a
n/a
n/achr1 32,268,715LCK proto-oncogene, Src family tyrosine kinase, transcript variant 2 (from RefSeq NM_005356.5)
28HLA-DQA2n/a
    
    
     
n/achr6 32,744,294major histocompatibility complex, class II, DQ alpha 2 (from RefSeq NM_020056.5)
29RHOHn/a
n/a
n/a
n/a
n/achr4 40,221,999ras homolog family member H, transcript variant 6 (from RefSeq NM_004310.5)
30PTPN22n/a
n/a
n/a
n/a
n/achr1 113,842,761protein tyrosine phosphatase non-receptor type 22, transcript variant 1 (from RefSeq NM_015967.8)
31MCOLN2n/a
n/a
n/a
n/a
n/achr1 84,961,348mucolipin TRP cation channel 2, transcript variant 1 (from RefSeq NM_153259.4)
32FCRL5n/a
n/a
n/a
n/a
n/achr1 157,532,946Fc receptor like 5, transcript variant 1 (from RefSeq NM_031281.3)
33TASLn/a
    
    
     
n/achrX 30,568,287TLR adaptor interacting with endolysosomal SLC15A4 (from RefSeq NM_025159.3)
34AIM2n/a
n/a
n/a
n/a
n/achr1 159,069,625absent in melanoma 2, transcript variant 1 (from RefSeq NM_004833.3)
35TCL1An/a
n/a
n/a
n/a
n/achr14 95,712,036TCL1 family AKT coactivator A, transcript variant 1 (from RefSeq NM_021966.3)
36MKI67n/a
n/a
n/a
n/a
n/achr10 128,111,541marker of proliferation Ki-67, transcript variant 1 (from RefSeq NM_002417.5)
37MIR146An/a
n/a
n/a
n/a
n/achr5 160,485,401microRNA 146a (from RefSeq NR_029701.1)
38IGHV1OR15-1n/a
    
    
     
n/achr15 22,160,649Immunoglobulins are composed of two identical heavy chains and  two identical light chains; disulfide-linked. (from UniProt A0A075B7D0)
39CCL3-AS1n/a
n/a
n/a
n/a
n/achr17 36,081,361CCL3-AS1 (from geneSymbol)
40GCSAMn/a
n/a
n/a
n/a
n/achr3 112,127,043germinal center associated signaling and motility, transcript variant 1 (from RefSeq NM_152785.5)
41ENSG00000258449n/a
    
    
     
n/achr12 25,098,924ENSG00000258449 (from geneSymbol)
42ITGA4n/a
n/a
n/a
n/a
n/achr2 181,498,163integrin subunit alpha 4, transcript variant 1 (from RefSeq NM_000885.6)
43NCR3n/a
n/a
n/a
n/a
n/achr6 31,590,950natural cytotoxicity triggering receptor 3, transcript variant 1 (from RefSeq NM_147130.3)
44TNFRSF8n/a
n/a
n/a
n/a
n/achr1 12,103,755TNF receptor superfamily member 8, transcript variant 1 (from RefSeq NM_001243.5)
45SLAMF1n/a
n/a
n/a
n/a
n/achr1 160,627,575signaling lymphocytic activation molecule family member 1, transcript variant 4 (from RefSeq NR_104401.3)
46BTLAn/a
n/a
n/a
n/a
n/achr3 112,481,719B and T lymphocyte associated, transcript variant 1 (from RefSeq NM_181780.4)
47LINC00996n/a
    
    
     
n/achr7 150,440,897long intergenic non-protein coding RNA 996 (from RefSeq NR_034033.1)
48ENSG00000260997n/a
    
    
     
n/achr7 44,959,954ENSG00000260997 (from geneSymbol)
49ENSG00000268027n/a
n/a
n/a
n/a
n/achr19 41,550,221ENSG00000268027 (from geneSymbol)
50MYBL2n/a
n/a
n/a
n/a
n/achr20 43,691,798MYB proto-oncogene like 2, transcript variant 1 (from RefSeq NM_002466.4)